Portfolio (Quarterly)
Guide ↗
Decheng Capital LLC
· CIK 0002010850| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | — | Upstream Bio Inc. | — | 2,724,868.0 | $24.5M | 3.71% | -418K | -13.3% | $9.00 | — |
| 2 | — | NEWAMSTERDAM PHARMA CO NV | — | 325,057.0 | $10.4M | 1.57% | -267K | -45.1% | $32.01 | — |
| 3 | RCUS | Arcus Biosciences, Inc | Healthcare | 477,819.0 | $10.3M | 1.56% | -64K | -11.8% | $21.60 | +8.0% |
| 4 | RVMD | REVOLUTION MEDICINES INC(NSM) | Healthcare | 93,500.0 | $9.1M | 1.38% | -106K | -53.2% | $97.25 | +52.7% |
| 5 | KRYS | KRYSTAL BIOTECH INC | Healthcare | 7,300.0 | $1.9M | 0.28% | -10K | -57.8% | $258.32 | +16.8% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%